MedPath

University of North Carolina - Chapel Hill Endowment Fund

🇺🇸United States
Ownership
Private, Subsidiary
Employees
-
Market Cap
-
Website

Nitric Oxide Mediated Vasodilatory Response to Hawthorn Standardized Extract

Phase 1
Completed
Conditions
Prehypertension
Mild Hypertension
Interventions
Dietary Supplement: Placebo capsule
Dietary Supplement: Hawthorn
First Posted Date
2011-04-08
Last Posted Date
2013-02-07
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
24
Registration Number
NCT01331486
Locations
🇺🇸

UNC Department of Family Medicine, Chapel Hill, North Carolina, United States

Curcumin Pharmacokinetics

Phase 1
Completed
Conditions
Comparative Multidose Pharmacokinetics
Interventions
First Posted Date
2011-04-07
Last Posted Date
2017-08-03
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
12
Registration Number
NCT01330810
Locations
🇺🇸

UNC Department of Family Medicine, Chapel Hill, North Carolina, United States

Pharmacokinetics of Tenofovir, Emtricitabine, Maraviroc, and Raltegravir in Cervical, Vaginal, and Rectal Tissues and Secretions

Phase 1
Completed
Conditions
Healthy Adult Females
Interventions
Other: Pharmacokinetic Sampling
First Posted Date
2011-04-06
Last Posted Date
2013-09-17
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
49
Registration Number
NCT01330199
Locations
🇺🇸

UNC Hospitals CTRC, Chapel Hill, North Carolina, United States

The Effects of a Self-management Intervention on Low Literacy Patients With Chronic Obstructive Pulmonary Disease (COPD)

Not Applicable
Completed
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
Behavioral: Self-Management Intervention
First Posted Date
2011-04-01
Last Posted Date
2011-04-01
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
99
Registration Number
NCT01327456
Locations
🇺🇸

University of North Carolina Hospitals Ambulatory Care Center, Chapel Hill, North Carolina, United States

Single Dose Truvada in HIV-negative Men and Women

Completed
Conditions
Pharmacokinetic Study in Healthy Volunteers
Interventions
First Posted Date
2011-03-30
Last Posted Date
2012-10-10
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
12
Registration Number
NCT01326221
Locations
🇺🇸

University of North Carolina, Chapel Hill, North Carolina, United States

Tadalafil for Sarcoidosis Associated Pulmonary Hypertension

Phase 2
Completed
Conditions
Pulmonary Hypertension
Interventions
First Posted Date
2011-03-29
Last Posted Date
2017-07-24
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
12
Registration Number
NCT01324999
Locations
🇺🇸

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

🇺🇸

University of Cincinnati, Cincinnati, Ohio, United States

Family PALS (PArtners in Lifestyle Support)

Not Applicable
Completed
Conditions
Diabetes Mellitus
Interventions
Behavioral: Adult diabetes family-based weight loss intervention
First Posted Date
2011-03-28
Last Posted Date
2013-07-17
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
108
Registration Number
NCT01324011
Locations
🇺🇸

UNC Center for Health Promotion and Disease Prevention (HPDP), Chapel Hill, North Carolina, United States

Managerial Database II

Completed
Conditions
Acquired Immunodeficiency Syndrome
First Posted Date
2011-03-24
Last Posted Date
2017-02-28
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
513
Registration Number
NCT01322217
Locations
🇺🇸

University of Colorado Denver, Aurora, Colorado, United States

🇺🇸

Johns Hopkins University, Baltimore, Maryland, United States

🇺🇸

Baylor College of Medicine - Pediatrics Allergy and Immunology, Houston, Texas, United States

and more 2 locations

Cardiovascular Effects in Psoriasis Patients Treated With Adalimumab.

Not Applicable
Completed
Conditions
Psoriasis
Interventions
First Posted Date
2011-03-22
Last Posted Date
2016-12-26
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
18
Registration Number
NCT01320293
Locations
🇺🇸

UNC Dermatology Clinical Trials Unit, Chapel Hill, North Carolina, United States

The Effect of Vorinostat on HIV RNA Expression in the Resting CD4+ T Cells of HIV+ Pts on Stable ART

Phase 1
Completed
Conditions
HIV-1 Infection
Interventions
First Posted Date
2011-03-21
Last Posted Date
2017-06-29
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
25
Registration Number
NCT01319383
Locations
🇺🇸

The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath